IMMU-02. TARGETING CD200 ACTIVATION RECEPTORS TO OVERCOME THE IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT: A NEW DIRECTION FOR CHECKPOINT IMMUNOTHERAPY
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.